Latest Bioinformatics NewsRSS

11:35 EDT 16th August 2017 | BioPortfolio

Applied StemCell Awarded $1.3 Mil USD From NIH for TARGATT™ Gene Editing

Applied StemCell, Inc. (ASC), a leading gene-editing company focused on the development of enabling tools and curative medicines using TARGATT™ and stem cell technologies, has just been awarded close to $1.3 million US dollars in a small Business Innovation Research (SBIR) grant from the NIH. The grant award will support the establishment of a Cre/LoxP rat ...

High obesity rates among African Americans may be linked to gene variant

Genetic Variance is Key to Individual Immune Response

Ever wonder why your friend, co-worker, or partner doesn’t get as sick as you, even though they caught the same “bug” you did? Maybe they made some Faustian bargain that affords them greater protection to infections, or perhaps they are part of some top-secret government experiment that injects them with an array of antigens isolated from an alien race living in Area 51. While both theories ...

Interview Released with Pharmaceutical Pricing Pioneer, Anita Burrell Ahead of 23rd Annual Pricing and Market Access Summit

London, United Kingdom, August 16, 2017 --( SMi Group are thrilled to release an interview Anita Burrell ahead of her presentation on the constraints of RCT's at the 23rd annual industry summit on Pharmaceutical Pricing & Market Access this Autumn. With significant breadth of experience in establishing value evidence across the top 10 therapeutic areas and former senior roles in...

Applied StemCell, Inc. Awarded $1.3 Mil USD From NIH For TARGAT Gene Editing

  Life Sciences Jobs   ...

Gene Expert: IRBs Should Prepare for Somatic Cell Trials

With somatic gene cell editing already underway in some trials, IRBs should prepare to deal with protocols involving noninheritable genetic changes.

Parkinson Disease: Functional Assessement, Gene Disruptions, and More

New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.

Gene Editing in Human Embryos Leaps Forward—Here’s the Science

Imagine walking down the street with a ticking time bomb in your chest, never knowing when your heart may explode. Or going through five decades of life, having kids, and always wondering when your mind will finally slip away from you. Or worse yet, knowing that one day the same will inevitably happen to your […]

#news #biotech Five researchers share $500,000 prize for work on gene editing

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Five researchers share $500,000 prize for work on gene editing .Five researchers will share a $500,000 medical prize for their roles in developing a groundbreaking gene-editing tool that … Continue reading → Cet article #news #biotech Five researchers share $500,00...

Dovetail Genomics Improves Coffee Breeding with High-quality Reference Genomes

In this webinar, which LabRoots will host September 20, attendees will learn the value of a high-quality genome assembly in plant research and improvement. Yorba Linda, Ca (PRWEB) August 15, 2017 Coffea arabica accounts for 70 percent of world coffee production and is threatened by various biotic and abiotic factors. During this educational webinar, participants will learn about the importance of...

Gene Editing Spurs Hope for Transplanting Pig Organs Into Humans

Geneticists have created piglets free of retroviruses, an important step toward creating a new supply of organs for transplant patients.

World-Leading Cancer Researchers Become First in the UK to Receive Latest Genome Sequencing Technology

UK scientists now have access to a new kind of next-generation genome sequencing machine which could revolutionise their research to defeat cancer. The high-tech genome sequencer – the Illumina NovaSeqTM 6000 – has been unveiled at The Institute of Cancer Research, London. The world-leading cancer research institute is the first in the UK to access the technology.....

Gene Therapy R&D and Revenue Forecasts 2017-2027

LONDON, August 15, 2017 /PRNewswire/ -- Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases The gene therapy market is projected to grow at a CAGR of 40.8% in the first half of the forecast period. In 2016, the cancer treatment submarket accounted for 75.0% of the gene therapy drug market. Visiongain estimated that gene therapy for rare diseases will be the driver for mar...

Episona Appoints Vice President of Sales

PASADENA, Calif., Aug. 15, 2017 /PRNewswire/ -- Episona Inc., an epigenetics data company focused on improving outcomes in reproductive health, announced today that it has appointed Bob King, formerly of Good Start Genetics and a veteran in the field of reproductive health, as vice president, sales. Mr. King will oversee the commercial expansion of Episona's Seed test for evaluating male fact...

Fortress adds 10th subsidiary to biotech network

The hyrbid biopharma/venture firm launched Aevitas Therapeutics Monday to develop gene therapies for two rare diseases. 

Could gene editing have saved Charlie Gard?

Loss of Circular RNA Throws Brain for a Loop

Circular RNAs (circRNAs), closed loops of noncoding RNA, drift through the cytoplasm like so many ring buoys floating on the sea. Precisely what the circRNAs are doing there hasn’t been clear. Because they are especially abundant in brain cells, circRNAs have been thought to have a role in brain function, possibly via the regulation of gene expression. This possibility looks more likely than eve...

New Technique Searches ?Dark Genome? for Disease Mutations

‘Orion’ will help researchers identify disease-causing mutations in patients when current methods come up dry.

Fortress Biotech Forms New Subsidiary, Aevitas Therapeutics, To Develop Novel AAV Gene Therapy Treatments For Complement-Mediated Diseases

  Life Sciences Jobs   ...

Your Genome May Become The Next

  Life Sciences Jobs   ...

Fortress Biotech Forms New Subsidiary, To Develop Novel AAV Gene Therapy Treatments For Complement-Mediated Diseases

  Life Sciences Jobs   ...

Local gene therapy improves myocardial blood flow in refractory angina patients

For the first time, researchers have employed local gene therapy to boost myocardial blood flow in areas that have impaired perfusion reserves. They have also determined that elevated plasma Lp(a) can serve as a biomarker to identify those individuals with refractory angina (RA) who can benefit from the experimental therapy, gene transfer of VEGF-DΔNΔC.

Coding redetermination for custom diabetic inserts announced

A publication released in July by the Medicare administrative contractor for durable medical equipment, which clarified the use of billing code A5513 for custom diabetic inserts, has spurred a coding redetermination that will end all previous A5513 verifications by the end of May 2018, according to a press release from the American Orthotic and Prosthetic Association (AOPA).The Medicare administra...

11 things CRISPR gene editing has helped us achieve this year

Synthace collaborates with Oxford BioMedica, Cell and Gene Therapy Catapult and Stratophase

The post Synthace collaborates with Oxford BioMedica, Cell and Gene Therapy Catapult and Stratophase appeared first on SynBioBeta.

Quick Search

review and buy Bioinformatics market research data and corporate reports here